Abeona Therapeutics (ABEO) Tops Q2 EPS by 209c

Abeona Therapeutics (NASDAQ: ABEO) reported Q2 EPS of $1.71, $2.09 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $400 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• AES stockholders approve $10.7 billion takeover by GIP and EQT
• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance